All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C16H25N3O2
CAS Number:
Molecular Weight:
291.39
MDL number:
assay
≥99%
SMILES string
CCN(CC)CCNC(=O)c1ccc(NC(=O)CC)cc1
InChI
1S/C16H25N3O2/c1-4-15(20)18-14-9-7-13(8-10-14)16(21)17-11-12-19(5-2)6-3/h7-10H,4-6,11-12H2,1-3H3,(H,17,21)(H,18,20)
InChI key
CTHPVGZIOICAFO-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J Kusowska
Acta poloniae pharmaceutica, 46(1), 90-97 (1989-01-01)
In the recent years a remarkable number of new antiarrhythmic drugs have been introduced, but their side effects limit the application. Procainamide (PA) and N-acetylprocainamide (Acekainide, NAPA) display many undesired side effects, too. It was assumed that N-propionyl-procainamide, having antiarrhythmic
[A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
J Kusowska
Acta poloniae pharmaceutica, 45(4), 346-350 (1988-01-01)
J Kusowska et al.
Acta poloniae pharmaceutica, 46(2), 187-194 (1989-01-01)
Procainamide (PA) often applied in cases of ventricular arrhythmias causes numerous cardiac and extracardiac undesirable symptoms. Its active metabolite, N-acetylprocainamide (NAPA; Acecainide) is known to affect less noxiously the ventriculo-atrial conduction and the intraventricular++ conduction, and it does not impair
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service